Primo Brands is a strong buy: integration is stabilizing, $300M synergies are on track, and an 8.2x EBITDA discount implies ...

Sepsis, a complex syndrome driven by a dysregulated host response to infection, is closely linked to both metabolic and ...

Akebia Therapeutics is refocusing on Vafseo for dialysis patients, discontinuing expansion to non-dialysis, which has reset ...

Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...

By dedicating this time to operational efficiency and data-driven guest engagement, operators can stop revenue bleed and ...

According to IWSR, global beverage alcohol volumes are under pressure, with wine consumption declining by roughly 1% to 2% ...

A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...

Nearly two-dozen players have entered their name into the portal with a change in the staff. A few of them have reconsidered ...

In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...

Mr. Olympia Danny Hester joins NF1 to advance science-backed training, recovery, and gut health through RESET and the NF1 performance platform. Training doesn’t stop working—you just need the right ...